Company Profiles

driven by the PitchBook Platform

Agenovir

Description

Developer of novel therapeutics. The company specializes in developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.

2014

Founded

PRIVATE

Status

Series A

Latest Deal Type

$10.6M

Latest Deal Amount

$10.6M

Total Amount Raised

5

Investors

Description

Developer of novel therapeutics. The company specializes in developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs.

Website:

www.agenovir.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

29 Oyster Point Boulevard 3rd Floor South San Francisco, CA 94080United States +1 (650) 491-9624
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Agenovir's full profile, request a free trial.

    Agenovir Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Agenovir Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Agenovir Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    California Institute for Quantitative BiosciencesAccelerator/Incubator000 0000000 0000
    CelgeneCorporationMinority000 0000000 0000
    Data CollectiveVenture CapitalMinority000 0000000 0000
    JLabsAccelerator/Incubator000 0000000 0000
    Lightspeed Venture PartnersVenture CapitalMinority000 0000000 0000
    California Institute for Quantitative Biosciences Accelerator/Incubator
    Celgene Corporation
    Data Collective Venture Capital
    JLabs Accelerator/Incubator
    Lightspeed Venture Partners Venture Capital

    Agenovir Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Dirk Thye MDBoard of Director, President & Chief Executive Officer
    Bolyn Hubby Ph.DChief Scientific Officer
    Angela WuCo-Founder & Advisor
    Dirk Thye MD Board of Director, President & Chief Executive Officer
    Bolyn Hubby Ph.D Chief Scientific Officer
    Angela Wu Co-Founder & Advisor

    Agenovir Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Bruce Hironaka JDAgenovirDirector000 0000
    Dirk Thye MDAgenovirBoard of Director, President & Chief Executive Officer000 0000
    Matthew OckoData CollectiveCo-Founder and Co-Managing Partner000 0000
    Stephen Quake Ph.DAgenovirCo-Founder & Chairman of the Scientific Advisory Board000 0000
    William SmithAgenovirBoard Member000 0000
    Bruce Hironaka JD Director Agenovir
    Dirk Thye MD Board of Director, President & Chief Executive Officer Agenovir
    Matthew Ocko Co-Founder and Co-Managing Partner Data Collective
    Stephen Quake Ph.D Co-Founder & Chairman of the Scientific Advisory Board Agenovir
    William Smith Board Member Agenovir
    Request full access to PitchBook